Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 20%
Buy 13%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health is a virtual healthcare services provider with two reportable segments, Integrated Care and BetterHelp, which offer primary care, mental health, and chronic care management services to employers, insurers, and healthcare systems. The company has strong underlying growth potential, especially with its chronic care offerings, and is well-positioned to capitalize on the expanding market for virtual care. Its unique virtual platform and ability to deliver whole-person care give it a clear advantage over competitors, and the recent spike in virtual care awareness due to the COVID-19 pandemic has only bolstered the company's growth. However, slower growth in its BetterHelp segment and increasing competition across all markets may create headwinds and hinder its ability to generate steady profitability. Longer-term, Teladoc's push into population health and its new service, Primary 360, could be the next leg of growth, but there remain uncertainties around the market for BetterHelp and the effectiveness of investing to drive future growth.

Bears say

Teladoc Health is facing some challenges with its recent push towards whole-person health, particularly in the newer and nascent market of Primary 360. The company's slowdown in revenue growth, driven by uncertainty in its BetterHelp segment, could have negative impacts on its long-term valuation, making it difficult to reach its estimated $5.50 price target. Additionally, while Teladoc has been a leader in virtual healthcare, the majority of healthcare is still delivered in person, and the company will need to continue to drive adoption of its virtual services to achieve ultimate success. However, the company's efforts to improve efficiency in advertising and expand its international presence show promise, and its insurance offering and solid cost management are positive factors. Competition across all markets could also pose a threat to Teladoc's economic returns.

Teladoc (TDOC) has been analyzed by 15 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 13% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 15 analysts, Teladoc (TDOC) has a Hold consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.